Elisa De La Cruz

Also affiliated with Université de Montpellier, Center for the Study of Social Policy, Hôpital Gui de Chauliac, Services déconcentrés d'appui à la recherche Occitanie-Montpellier

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial”.

Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial

The Lancet Neurology(2024)10.1016/s1474-4422(24)00373-9

N/A

0.653DataRank · unranked

31 citations

Andreas Leha, Helen Bidner, Isabell Cordts, Johannes Dorst, René Günther +28 more